News

  • Trustedoctor merges with insurance firm

    Digital healthcare platform Trustedoctor has merged with an insurance firm with the aim of providing a new healthcare solution provider. Further specialises in the design and development of cross-border insurance services for serious illnesses, while Trustedoctor focuses on giving users access to world-leading international medical expertise. The merged companies will provide a new holistic healthcare insurance [...]

  • Stanford researchers developing single dose vaccine

    Researchers at Stanford are working to develop a single dose vaccine for COVID-19 that could potentially be stored at room temperature. Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. However, within days of closing their campus lab space as part of [...]

  • NHS begins testing phase of private care data programme

    The testing phase of a programme that will see data on privately funded care from independent hospitals collected by the NHS for the first time has begun. If successful, the pilot will pave the way for a comprehensive national dataset of public and private hospital data in England, facilitating the production of whole-practice information for [...]

  • CliniSys launches new laboratory information management system

    CliniSys has launched a new laboratory information management system for genomic hubs in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being deployed at Poitiers University Hospital in France and will be introduced into seven additional laboratories in coming months. GLIMS Genomics has been designed to support the effective management of genomic laboratories, with the NHS now [...]

  • Platform developed to detect COVID-19 antibodies within seconds

    Researchers at Carnegie Mellon University have reported findings on an advanced nanomaterial-based biosensing platform that detects COVID-19 antibodies within seconds. The results were published inthe journal Advanced Materials. Carnegie Mellon's collaborators included the University of Pittsburgh and the UPMC. The testing platform identifies the presence of two of the virus' antibodies, spike S1 protein and receptor [...]

  • Locate Bio awarded FDA designation for osteomyelitis device

    Nottingham-based Locate Bio has been granted FDA Breakthrough Device Designation for its device currently in development for the treatment of osteomyelitis. The FDA Breakthrough Device Program is intended to help patients receive more timely access to certain technologies that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases [...]

  • Greenlight Guru partners with global laboratory testing firm

    US-based Greenlight Guru, a medical device quality management software platform, has partnered with a global provider of laboratory testing and advisory services. Nelson Labs offers more than 800 tests, employing more than 500 scientists in its 13 global laboratory facilities. Through this strategic alliance between the two brands, medical device companies gain access to Greenlight Guru’s [...]

  • COVID-19 sequencing project awarded £1.2m funding

    Supercomputing facilities set up to track the spread and evolution of the COVID-19 pandemic has been awarded £1.2m in government funding to expand globally. The new funding will enable the CLIMB COVID-19 project, led by the University of Birmingham and Cardiff University, to carry out significant upgrades to its computational equipment, enabling it to process and [...]

  • IMMJ Systems secures £3.5m investment

    IMMJ Systems, an electronic document management solution supplier for the healthcare industry, has secured a £3.5m growth capital investment from investment manager Foresight Group. Founded in 2015, by a team experienced in enterprise IT and NHS technology distribution, IMMJ developed MediViewer. The platform digitises patient records and provides a single, easy access interface for clinical [...]

  • Brain surgery alternative shows promise for Parkinson’s disease

    A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson's disease symptoms that are much more severe on one side of the body, according to new research. The approach, which uses a technology called focused ultrasound, could offer a new option for patients whose symptoms are poorly controlled by medications and [...]